Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in Iran

Publisher： Karger

E-ISSN： 1421-9913|52|4|202-206

ISSN： 0014-3022

Source： European Neurology, Vol.52, Iss.4, 2004-12, pp. : 202-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Treatment of Multiple Sclerosis with Beta-Interferon

By  

Neuroepidemiology, Vol. 31, Iss. 3, 2008-08 ,pp. : 157-158

Karger

Access to resources Recommend Favorite

Effect of Interferon-beta-1b on Cognitive Functions in Multiple Sclerosis

By  

European Neurology, Vol. 47, Iss. 1, 2002-01 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 167-168

Karger

Access to resources Recommend Favorite

Coping Strategy and Anxiety Evolution in Multiple Sclerosis Patients Initiating Interferon-Beta Treatment

By  

European Neurology, Vol. 62, Iss. 2, 2009-06 ,pp. : 79-85

Karger

Access to resources Recommend Favorite

Beta-Interferon Treatment Reduces Human Herpesvirus-6 Viral Load in Multiple Sclerosis Relapses but Not in Remission

By  

European Neurology, Vol. 52, Iss. 2, 2004-09 ,pp. : 87-91

Karger

Access to resources Recommend Favorite